Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia

Abroad (travel likely)Recruiting

Conditions

COPD · Idiopathic Pulmonary Fibrosis (IPF) · Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

IRCCS Fondazione Don Carlo Gnocchi, Milan, Milan, Italy
Contact: Study coordinator (Simone Agostini, PhD) · sagostini@dongnocchi.it · +390240308375
Contact: Study coordinator (Federica Piancone, PhD) · fpiancone@dongnocchi.it · +390240308211

Study leads

Mario Clerici, MD
Principal Investigator
IRCCS Fondazione Don Carlo Gnocchi

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Diaphragmatic Function as a Biomarker

Dyspnea; Asthmatic · COPD · Fibrosis

Abroad (travel likely)Recruiting

Aachen, Germany

SWEEP: Shuttle Walking Test for Exercise Evaluation in Pulmonary Resection

COPD · ILD · Bronchiectasis

Abroad (travel likely)Recruiting

Seongnam-si, South Korea

DEPRECAP: Lung Cancer Screening Programme by LDCT for Patients With COPD or Emphysema.

Lung Cancer · COPD · Emphysema

Abroad (travel likely)Recruiting

Madrid, Spain · Madrid, Spain

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

COPD (Chronic Obstructive Pulmonary Disease)

Abroad (travel likely)RecruitingPHASE2

Miami Lakes, United States · North Dartmouth, United States